Cheyenne Johnson

Also affiliated with British Columbia Centre on Substance Use

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Socioeconomic marginalization and risk of overdose in a community-recruited cohort of people who use drugs: A longitudinal analysis”.

Socioeconomic marginalization and risk of overdose in a community-recruited cohort of people who use drugs: A longitudinal analysis

International Journal of Drug Policy(2023)10.1016/j.drugpo.2023.104117

N/A

0.406DataRank · unranked

14 citations

JinCheol Choi, Jenna van Draanen, Thomas Kerr, Mark Gilbert, Kanna Hayashi +4 more

Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy

Addiction Science & Clinical Practice(2022)10.1186/s13722-022-00354-x

N/A

0DataRank · unranked

0 citations

Kora DeBeck, Nadia Fairbairn, Zishan Cui, Rupinder Brar, Dean Wilson +4 more

Community Pharmacy‐Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program

Drug and Alcohol Review(2025)10.1111/dar.70062

N/A

0DataRank · unranked

0 citations

M. Eugenia Socías, Karen McCrae, Cheyenne Johnson, Seonaid Nolan, Cameron Grant +3 more